News
- Details
The Medsintez plant is an innovative pharmaceutical enterprise that manufactures vital and major medicines. Today, the plant's developments are focused on the area, which is among the most demanded ones by the Russian healthcare system, namely creating drugs for diabetes. Read on to find out how the company operates on the modern biotech market.
- Details
- Details
The coronavirus pandemic has become a serious test for thousands of Russian enterprises. Some of them failed to adapt to the new reality and dropped out of the game. Others have become the vanguard in the fight against COVID-19 and its consequences. Medsintez, a pharmaceutical plant, is in their number. In 2020, it assumed an extra responsibility for the quality and duration of life of Russia citizens.
- Details
The government commission for more sustainable development of the Russian economy, according to its meeting's minutes No. 13-КЗ of June 19, 2020, included the Medsintez plant into the list of the Russian Federation's systemic enterprises whose products or services are vital for sustaining a territory, functioning of an industry and a region's social and economic system.
- Details
In June 2020, the Medsintez plant entered an agreement to join the Bioorganika Consortium of the Center for the National Technological Initiative of the Federal State Budgetary Institution 'Institute of Bioorganic Chemistry named after Academicians M. M. Shemyakin and Yu. A. Ovchinnikov' of the Russian Academy of Sciences (IBCh RAS).
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130